Sleep deprivation (SD) is known to
be associated with metabolic
disorders and chronic diseases. Complex metabolic alterations induced
by SD at omics scale and the associated biomarker candidates have
been proposed. However, in vivo systemic and local metabolic shift
patterns of the metabolome and lipidome in acute and chronic partial
SD models remain to be elucidated. In the present study, the serum,
hypothalamus, and hippocampus CA1 of sleep-deprived rats (SD rats)
from acute and chronic sleep restriction models were analyzed using
three different omics platforms for the discovery and mechanistic
assessment of systemic and local SD-induced dysregulated metabolites.
We found a similar pattern of systemic metabolome alterations between
two models, for which the area under the curve (AUC) of receiver operating
characteristic curves was AUC = 0.847 and 0.930 with the pseudotargeted
and untargeted metabolomics approach, respectively. However, SD-induced
systemic lipidome alterations were significantly different and appeared
to be model-dependent (AUC = 0.374). Comprehensive pathway analysis
of the altered lipidome and metabolome in the hypothalamus indicated
the abnormal behavior of eight metabolic and lipid metabolic pathways.
The metabolic alterations of the hippocampus CA1 was subtle in two
SD models. Collectively, these results extend our understanding of
the quality of sleep and suggest metabolic targets in developing diagnostic
biomarkers for better SD control.